Correction: Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C.

Autor: Marta Gallach, Mercedes Vergara, Joao Pedro da Costa, Mireia Miquel, Meritxell Casas, Jordi Sanchez-Delgado, Blai Dalmau, Núria Rudi, Isabel Parra, Teresa Monllor, Meritxell Sanchez-Lloansí, Angelina Dosal, Oliver Valero, Xavier Calvet

Publikováno v: PLoS ONE, Vol 15, Iss 10, p e0241559 (2020)

[This corrects the article DOI: 10.1371/journal.pone.0208112.].

Externí odkaz: https://doaj.org/article/5129c8b9691749f092aaacf1085dfd61

Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C.

Autor: Marta Gallach, Mercedes Vergara, Joao Pedro da Costa, Mireia Miquel, Meritxell Casas, Jordi Sanchez-Delgado, Blai Dalmau, Núria Rudi, Isabel Parra, Teresa Monllor, Meritxell Sanchez-Lloansí, Angelina Dosal, Oliver Valero, Xavier Calvet

Publikováno v: PLoS ONE, Vol 13, Iss 12, p e0208112 (2018)

BACKGROUND AND AIM:Treatment of hepatitis C with direct-acting antiviral agents (DAA) has few side effects. Although pivotal studies suggested that DAA were safe in patients with psychiatric diseases who could not be treated with previous antiviral t

Externí odkaz: https://doaj.org/article/91db3feabd944fe8b221f4d7fdf932bc

Adherencia en pacientes en tratamiento crónico: resultados del “Día de la Adherencia” del 2013

Autor: Barrueta, Olatz Ibarra ^*, Verdugo, Ramón Morillo, Sola, Nuria Rudi, Cerdá, José Manuel Ventura, Aznárez, Herminia Navarro

Publikováno v: In Farmacia Hospitalaria March-April 2015 39(2):109-113

Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C

Autor: Mireia Miquel, Meritxell Casas, Joao Pedro da Costa, Xavier Calvet, Oliver Valero, Teresa Monllor, Blai Dalmau, Isabel Parra, Jordi Sánchez-Delgado, Angelina Dosal, Mercedes Vergara, Núria Rudi, Marta Gallach, Meritxell Sanchez-Lloansí

Publikováno v: PLoS ONE
PLoS ONE, Vol 13, Iss 12, p e0208112 (2018)

Background and aim Treatment of hepatitis C with direct-acting antiviral agents (DAA) has few side effects. Although pivotal studies suggested that DAA were safe in patients with psychiatric diseases who could not be treated with previous antiviral t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b79a425e21d4fac7955cd0169bbc2e14
https://ddd.uab.cat/record/253765

Omalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study

Autor: Núria Rudi, Ana Sogo, Ignacio Dávila, Christian Domingo, Albert Navarro, Rosa Mirapeix, Xavier Pomares

Publikováno v: International Journal of Molecular Sciences, Vol 18, Iss 3, p 521 (2017)
International Journal of Molecular Sciences
GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
International Journal of Molecular Sciences; Volume 18; Issue 3; Pages: 521

[EN] Omalizumab is marketed for chronic severe asthma patients who are allergic to perennial allergens. Our purpose was to investigate whether omalizumab is also effective in persistent severe asthma due to seasonal allergens. Thirty patients with or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68500a7237c5103e1a81bb8c2e44cdd8
http://www.mdpi.com/1422-0067/18/3/521